港股反弹！获资金“越跌越买”的港股通科技ETF基金、恒生医药ETF涨超1%

Core Viewpoint - Hong Kong stocks opened higher with the Hang Seng Technology Index rising over 1%, driven by gains in tech and innovative pharmaceutical sectors [1] Group 1: Market Performance - The Hang Seng Technology Index increased by more than 1%, with notable gains in JD Health and Bilibili, both rising over 4%, and Alibaba Health and Alibaba rising over 3% [1] - The Hang Seng Pharmaceutical ETF and Hong Kong Stock Connect Technology ETF both saw increases of over 1% [1] Group 2: Economic Indicators - Federal Reserve Chairman Jerome Powell warned of further challenges in the U.S. labor market, suggesting a potential interest rate cut before the October monetary policy meeting [1] Group 3: New Financial Products - Hong Kong Stock Exchange announced plans to launch the Hang Seng Biotechnology Index futures, set to begin trading on November 28, 2025, aimed at providing precise risk management tools for investors [1] Group 4: Fund Flows - Despite a cumulative decline of over 9% in the Hong Kong Stock Connect Technology ETF from October 9 to October 14, there was a net inflow of 270 million yuan during this period [1] - The Hang Seng Pharmaceutical ETF experienced a decline of over 10% but still attracted a net subscription of 175 million yuan [1] - The defensive Hong Kong Central Enterprise Dividend ETF received a net inflow of 279 million yuan amid renewed focus on dividend strategies [1] Group 5: Notable Products - The Hang Seng Pharmaceutical ETF (159892) rose by 1.04%, with top-weighted stocks including innovative pharmaceutical companies like BeiGene and WuXi Biologics [2] - The Hong Kong Stock Connect Technology ETF (159101) increased by 1.01%, with over 60% exposure to major tech firms like Alibaba and Tencent, and a special focus on innovative drugs [2] - The Hong Kong Central Enterprise Dividend ETF (513910) rose by 0.88%, including major stocks such as COSCO Shipping and China Petroleum [2]